{"title":"The Supreme People’s Court of China ruled on the first pharmaceutical patent linkage case after the new Patent Law","authors":"Hongxuyang Lu","doi":"10.1093/jiplp/jpad004","DOIUrl":null,"url":null,"abstract":"Abstract In the first case regarding the pharmaceutical patent linkage regime in China, the Supreme People’s Court of China ruled that the validity of a patent did not affect a pharmaceutical patent linkage case. Whether the technical solution of the generic drug falls within the scope of protection of a patent should be judged based on the submitted application for marketing authorization, instead of the actual technical solution implemented.","PeriodicalId":44529,"journal":{"name":"Journal of Intellectual Property Law & Practice","volume":"13 1","pages":"0"},"PeriodicalIF":0.6000,"publicationDate":"2023-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Intellectual Property Law & Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jiplp/jpad004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"LAW","Score":null,"Total":0}
引用次数: 0
Abstract
Abstract In the first case regarding the pharmaceutical patent linkage regime in China, the Supreme People’s Court of China ruled that the validity of a patent did not affect a pharmaceutical patent linkage case. Whether the technical solution of the generic drug falls within the scope of protection of a patent should be judged based on the submitted application for marketing authorization, instead of the actual technical solution implemented.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
